---
figid: PMC8117216__fonc-11-670804-g001
figtitle: Repositioning of Antiparasitic Drugs for Tumor Treatment
organisms:
- Trypanosoma cruzi
- Plasmodium vivax
- Clonorchis sinensis
- Opisthorchis viverrini
- Schistosoma haematobium
- Streptomyces avermitilis
- Streptomyces bingchenggensis
- Streptomyces sp. FJS31-2
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Artemisia annua
organisms_ner:
- Rattus norvegicus
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8117216
filename: fonc-11-670804-g001.jpg
figlink: /pmc/articles/PMC8117216/figure/f1/
number: F1
caption: Efficacy of macrolide antiparasitic drugs in cancer. Apoptosis is the chief
  mechanism used by macrolide drugs to kill cancer cells. Macrolides trigger apoptosis
  through the (1) mitochondrial pathway, (2) cell cycle arrest, and (3) inhibition
  of the current of Ca2+ ion-activated Cl- channels. Other than apoptosis, macrolides
  can cause autophagic death of cancer cells by (4) degrading PAK1. When used for
  cancer cells, macrolides show selectivity for CSCs by (5) inhibiting stem cell genes
  and inactivating PAK1. Macrolides also reverse the abnormal epigenetics of tumor
  cells through (6) the combination of PAH2 and SID domain. By binding to the extracellular
  segment of EGFR, macrolides can (7) inhibit the transcription of P-gp, thereby reversing
  tumor resistance in which MDR and MASTA1 are also involved.
papertitle: Repositioning of Antiparasitic Drugs for Tumor Treatment.
reftext: Yan-Qi Li, et al. Front Oncol. 2021;11:670804.
year: '2021'
doi: 10.3389/fonc.2021.670804
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: drug repositioning | antiparasitic drugs | macrolides | benzimidazoles |
  artemisinin | quinolines | autophagy | ferroptosis
automl_pathway: 0.9575504
figid_alias: PMC8117216__F1
figtype: Figure
redirect_from: /figures/PMC8117216__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8117216__fonc-11-670804-g001.html
  '@type': Dataset
  description: Efficacy of macrolide antiparasitic drugs in cancer. Apoptosis is the
    chief mechanism used by macrolide drugs to kill cancer cells. Macrolides trigger
    apoptosis through the (1) mitochondrial pathway, (2) cell cycle arrest, and (3)
    inhibition of the current of Ca2+ ion-activated Cl- channels. Other than apoptosis,
    macrolides can cause autophagic death of cancer cells by (4) degrading PAK1. When
    used for cancer cells, macrolides show selectivity for CSCs by (5) inhibiting
    stem cell genes and inactivating PAK1. Macrolides also reverse the abnormal epigenetics
    of tumor cells through (6) the combination of PAH2 and SID domain. By binding
    to the extracellular segment of EGFR, macrolides can (7) inhibit the transcription
    of P-gp, thereby reversing tumor resistance in which MDR and MASTA1 are also involved.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pak1
  - Pkn1
  - Nanog
  - Qsox1
  - Ano1
  - Bcl2
  - Bax
  - Bc1
  - Ccne1
  - Akt1
  - Mtor
  - Pgp
  - Il6
  - MAST1
  - Cd24
  - Cd44
  - Gabrg2
  - Pou5f1
  - Sox2
  - Nkx3-1
  - Bc1-ps1
  - Igkv1-136
  - ci
  - Casp9
  - Casp3
  - Abcb1a
  - Abcb1b
  - Mod2
  - Mast1
  - Cd24a
  - PAK1
  - PKN1
  - WARS1
  - NANOG
  - POU5F1
  - POU5F1P3
  - POU5F1P4
  - SOX2
  - ANO1
  - BCL2
  - BAX
  - CHMP2A
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - ABCB1
  - IL6
  - CLASP1
  - CD24
  - CD44
  - Pak
  - CG11700
  - Sid
  - anon-70Dc
  - LanB2
  - anon-70Db
  - Debcl
  - bc2
  - BC1
  - ec
  - CycE
  - cyc
  - Dronc
  - Decay
  - Akt
  - Tor
  - Mdr65
---
